PEPTONIC Medical AB announces that the company has signed a license agreement with Swiss medical technology company Prima Lab SA regarding self-tests for urinary tract infections for sale in Sweden. The agreement means that Peptonic gets the right to sell Prima Lab's self-test for urinary tract infections under its own brand VagiVital® in Sweden, with a planned launch at the end of 2023. Prima Lab is a Swiss medical technology company with a specific focus on self-tests for women's health.

The company conducts its own research and development and sells its products in more than thirty countries around the world. Prima Lab's self-test for urinary tract infections has a high level of precision as it measures on four parameters - blood, protein, leukocytes and nitrites - unlike most other products that measure only two or three parameters. Prima Lab is already a strategic partner to Peptonic as Prima distributes Peptonics patented test for amniocentesis exclusively in a number of selected markets in Europe.